Viral Diversity an Innovative Biomarker for Refining Estimates of HIV Incidence
Viral Diversity an Innovative Biomarker for Refining Estimates of HIV Incidence
批准号:
10676203
负责人:
Sikhulile Moyo
金额:
$13.65万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2027-06-30
关键词:
2019-nCoVAIDS preventionAdoptedAdvisory CommitteesAfricanAlgorithmsAreaBioinformaticsBiological AssayBiological MarkersBiometryCountryCross-Sectional StudiesDataDevelopmentDevelopment PlansEpidemicEpidemiologyEvaluationExclusionGenetic RecombinationGenomeGenomicsGenotypeHIVHIV GenomeHIV InfectionsHIV-1IncidenceIndividualInfectionInstitutionInterventionLaboratoriesLeadershipLengthLongitudinal StudiesMeasurementMeasuresMentorsMentorshipMethodologyMethodsModelingMolecularMolecular EpidemiologyMonitorOutcomePatientsPersonsPhylogenetic AnalysisPolicy MakerPopulationPrevention ResearchProcessPublic HealthRNAResearchResearch PersonnelResearch Project GrantsResource-limited settingRoleSamplingSensitivity and SpecificitySerologySpecificitySpecimenStudentsSupervisionSurveysTestingTimeTrainingTraining ActivityUncertaintyViralViral GenomeVirusVirus Replicationantiretroviral therapybioinformatics pipelinecareercareer developmentcostcost effectiveexperiencegenome sequencingimprovedinnovationlongitudinal analysislow income countrynext generation sequencingpotential biomarkerpractical applicationpre-exposure prophylaxisprogramsprospectivepublic health emergencyresponsescale upscreeningsegregationseroconversionskillstooltransmission processtrend
中文摘要
项目摘要
候选人:Sikhulile Moyo博士坚定不移地致力于其主要的职业生涯,专注于为
结束艾滋病毒流行和相关的突发公共卫生事件。他致力于职业生涯,专注于寻找
成本效益高的工具,用于估计干预措施的影响和用于艾滋病毒治愈研究。他的设想是
他作为全球领导者,在旨在跟踪和消除新的艾滋病毒感染的研究中-朝着
开发艾滋病毒治疗方法,与研究人员、计划实施者和政策制定者合作,以实现快速和
对干预措施进行成本效益评估。莫约博士的5年职业发展计划主要集中在三个关键方面
领域:系统发育、流行病学和生物统计;横截面发病率和执行情况;以及艾滋病毒
早期创始病毒的治疗和特征,以及SARS-COV-2基因组学。为了达到他的短期目标-
和中期职业目标:a)在以下方面发展高级方法和分析技能
分子流行病学、系统发育分析和生物信息学;b)实时扩展实验室专门知识
高通量下一代测序和准确可靠的前驱油藏定量
推进艾滋病毒治愈研究,以及c)加强领导能力,特别是在管理大型科学研究方面
项目、人口水平调查和在不同领域拥有专业知识的不同研究团队,组织
领导力和学生研究督导。培训活动将包括正式培训和
课程工作,通过提议的研究项目的实际应用,以及我的高级导师
经验丰富的导师和顾问团队。这些活动将利用导师团队的优势。
和领先的研究机构,有很强的合作关系,并有指导年轻人的记录
调查人员到R01和独立。
研究:该研究旨在引入一种估计艾滋病毒发病率的创新方法,这一方法非常
对国家艾滋病毒方案/公共卫生很重要,对艾滋病毒预防研究也很重要,但可能
这样做既昂贵又具有挑战性。具体目标是:1)评估调整后的病毒多样性作为潜在的
艾滋病毒发病率的生物标志物。2)提炼真新近和假新近血清学筛查结果
病例和已确定感染的患者(ART-幼稚和ART),通过调整病毒多样性。我们将测试
HIV-1C基因组中信息量最大的区域内的病毒多样性是否根据多样性进行了调整
传播、重组和病毒复制水平的关系可以用来改进血清学结果
筛查并提高特异性和敏感性。我们预计调整后的病毒多样性在最
信息性区域将提高在估计艾滋病毒发病率的4个亚组中的特异性和敏感性
这一目标中的个人目标是≥95%。建立一个经济有效的算法来估计发病率是
在低资源环境下对公共卫生的关键重要性。
英文摘要
Project Summary
Candidate: Dr Sikhulile Moyo is unwaveringly committed to an overarching career focused on contributing to
ending the HIV epidemic and related public health emergencies. He committed to a career focused on finding
cost-effective tools for estimating the impact of interventions and towards HIV cure research. He envisions
himself as a leader globally, in research aimed towards tracking and eliminating new HIV infections & towards
developing an HIV cure, working with researchers, program implementers and policy makers for rapid and
cost-effective evaluation of interventions. Dr Moyo’s 5-year career development plan is focused on three key
areas: phylogenetics, epidemiology and biostatistics; cross-sectional Incidence and Implementation; and HIV
cure & characterization of early founder viruses, and SARS-COV-2 genomics. In order to achieve his short-
and medium-term career objectives he seeks to: a) develop advanced methodologic and analytic skills in
molecular epidemiology, phylogenetic analysis and bioinformatics; b) expand laboratory expertise in real-time
high-throughput next generation sequencing and accurate and reliable quantification of proviral reservoirs for
advancing HIV cure studies, and c) strengthen leadership abilities particularly in managing large scientific
projects, population-level surveys, and diverse research teams with expertise in different fields, organizational
leadership and student research supervision. Training activities will encompass formal training and
coursework, practical application through the proposed research project, and direct mentorship from my highly
experienced mentorship and advisory team. These activities will draw on the strengths of the mentorship team
and leading research institutions with strong collaborative ties and have a record of mentoring young
investigators to R01 and independence.
Research: The study aims to introduce an innovative approach to estimating HIV incidence, which is very
important for national HIV programs / public health, and also for HIV prevention research, but can be
expensive and challenging to do. The specific aims are: 1) To assess adjusted viral diversity as a potential
biomarker of HIV incidence. 2) To refine results of serological screening in subsets of true- and false-recent
cases, and patients with established infection (ART-naïve and on ART), by adjusted viral diversity. We will test
whether viral diversity within the most informative regions across the HIV-1C genome adjusted for multiplicity
of transmission, recombination, and level of viral replication could be used to refine the results of serological
screening and improve specificity and sensitivity. We expect that the adjusted viral diversity within the most
informative regions will increase specificity and sensitivity in estimation of HIV incidence within the 4 subsets of
individuals targeted in this Aim to ≥95%. Establishing a cost-effective algorithm to estimate incidence is of
critical public health importance in low resource settings.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.ijregi.2023.11.002
发表时间:
2024-03
期刊:
IJID REGIONS
影响因子:
--
作者:
[Makhema, Joseph, Shava, Emily, Izu, Alane, Gaolathe, Tendani, Kuate, Lesego, Walker, Adam, Carty, Lucy, Georgiou, Panayiotis, Kgathi, Coulson, Choga, Wonderful T., Sekoto, Tumalano, Seonyatseng, Ngozana, Mogashoa, Tuelo, Maphorisa, Comfort N., Mohammed, Terence, Ntalabgwe, Tshenolo, Frank, Tshepho T., Matlhaku, Boitumelo, Diphoko, Ame, Phindela, Thandie, Kaunda, Agripa, Kgari, Poloko, Kanyakula, Thomas, Palalani, Gape, Phakedi, Isabella, Mmalane, Mompati, Taylor, Sylvia, Moyo, Sikhulile]
通讯作者:
Moyo, Sikhulile
Comparison of the AmpFire Multiplex HPV Assay to the Xpert HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: A pragmatic performance evaluation.
AmpFire 多重 HPV 检测与 Xpert HPV 检测在检测人类免疫缺陷病毒女性中的人乳头瘤病毒和宫颈疾病方面的比较:实用的性能评估。
DOI:
10.21203/rs.3.rs-2606441/v1
发表时间:
2023
期刊:
Research square
影响因子:
--
作者:
[Moyo,Sikhulile, Ramogola-Masire,Doreen, Moraka,Natasha, Tawe,Leabaneng, Noubary,Farzad, Motsumi,Kesego, Manowe,Godiraone, Zuze,Boitumelo, Radibe,Botshelo, Hungwe,FaithTt, Mohammed,Terence, Maphorisa,Comfort, Shapiro,Roger, Gaseitsiwe,Simani]
通讯作者:
Gaseitsiwe,Simani
Viral Diversity an Innovative Biomarker for Refining Estimates of HIV Incidence
-
批准号:10538707
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2022
-
负责人:Sikhulile Moyo
-
依托单位:
海外基金